Insider trades
Troy A. Ignelzi, Director of Contineum Therapeutics CTNM, has filed 2 purchases and 13 sales on the open market. The latest trade was on 06/26.
Troy A. Ignelzi
Director
- Company
- Contineum Therapeutics CTNM
- First filing
- 23/02/13
- Trades
- 37 trades
- Buys / sales
- 2 / 13
- 12-month net buying
- No record
- Last trade
- 06/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
RAPP | Open-market buy | 25/03/12–25/03/13 | 25/03/13 | 10,000 sh2 trades | $10.10avg. | $100,988 | No record |
| Open-market sale10b5-1 plan | 23/08/22 | 23/08/24 | 1,500 sh4 trades | $175.12avg. | $262,682.55 | −4.7% | |
| Open-market sale10b5-1 plan | 23/05/23 | 23/05/25 | 9,000 sh6 trades | $223.41avg. | $2,010,661.67 | −22.8% | |
| Open-market sale | 23/02/21 | 23/02/23 | 6,000 sh | $190.01 | $1,140,060 | −16.4% | |
| Open-market sale | 23/01/17–23/01/18 | 23/01/19 | 1,017 sh2 trades | $201.16avg. | $204,579.97 | −4.4% |
